GLOW BPC 157 10mg + GHK-CU 50mg + TB500 10mg Strength: 70 mg CAS: BPC-157: 137525-51-0 GHK-Cu: 49557-75-7 TB500: 885340-08-9 Chemical Formula: GHK-Cu: CH4NO BPC-: CHNO TB: CHNO Molecular weight: GHK-Cu: 340.38 g/mol BPC-157: 1419.535 g/mol TB-500(TB-4): 889.0 g/mol Peptide Sequence: GHK-Cu: Gly-His-Lys (GHK) BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser Synonyms: glow, bpc157, tb500, thymosin beta 4, tb4, ghkcu, BPC-157, TB-500(TB-4) Storage: Store 28 C (20 C long-term)
See the full evidence review for a study-by-study breakdown
More specifically, the researchers share that they conducted an additional investigation into the potential of CJC-1295 on a murine model of GHRH gene ablation (GHRHKO) and related growth decline
Ok, so these are interesting points but please add this into the mix for future answers: The NICE Guideline clearly states that there is insufficient research why some people need more frequent injections than others and that an 8- or 12- weekly schedule does not work for everyone and some may need more frequently
This is impractical for most people
However, clinical evidence tells a more nuanced story